MT Educare Intrinsic Value
MT Educare (MTEDUCARE) median intrinsic value is ₹5.67 from 6 valuation models (range ₹3–₹6), vs current price ₹1.89 — +200.0% upside (Trading Below Calculated Value), margin of safety 66.7%. Read MTEDUCARE dividend yield for the complete payout history and dividend yield track record.
MTEDUCARE Valuation Methods Summary — DCF, Graham Number & P/E
MT Educare intrinsic value across 6 models vs current price ₹1.89 — upside/downside and value range per method. For current market price and key ratios, visit MT Educare stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹5.67 | ₹4.54 - ₹6.80 | +200.0% | EPS: ₹1.44, Sector P/E: 12x |
| Revenue Multiple Method | revenue | ₹3.78 | ₹3.40 - ₹4.16 | +100.0% | Revenue/Share: ₹6.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹3.78 | ₹3.40 - ₹4.16 | +100.0% | EBITDA: ₹28.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹2.58 | ₹2.06 - ₹3.10 | +36.5% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹5.67 | ₹5.10 - ₹6.24 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹5.67 | ₹5.10 - ₹6.24 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
MTEDUCARE Intrinsic Value vs Market Price — All Valuation Models
MT Educare fair value range ₹3–₹6 vs current market price ₹1.89 across 6 valuation models. Analyse MTEDUCARE promoter holding to track promoter, FII and institutional holdings.
MTEDUCARE Intrinsic Value Analysis — Undervalued or Overvalued?
MT Educare median intrinsic value ₹5.67, current price ₹1.89 — Trading Below Calculated Value by 200.0%, margin of safety 66.7%.
What is the intrinsic value of MTEDUCARE?
Based on our comprehensive analysis using 6 different valuation methods, the estimated intrinsic value of MT Educare (MTEDUCARE) is ₹5.67 (median value). With the current market price of ₹1.89, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹2.58 to ₹5.67, indicating ₹2.58 - ₹5.67.
Is MTEDUCARE undervalued or overvalued?
Based on our multi-method analysis, MT Educare (MTEDUCARE) appears to be trading below calculated value by approximately 200.0%.
MTEDUCARE Financial Health — Key Ratios vs Industry Benchmarks
MT Educare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.62 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -240.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 49.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.19x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
MTEDUCARE Cash Flow Quality — Operating & Free Cash Flow
MT Educare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |